Loading...
GlucoTrack, Inc.
IGAP•NASDAQ
HealthcareMedical - Instruments & Supplies
$3.24
$0.09(2.86%)
GlucoTrack, Inc. (IGAP) Stock Overview
Explore GlucoTrack, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for IGAPStats details for IGAP are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for IGAPAnalyst Recommendations details for IGAP are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Europe and the Asia Pacific. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.
CEO
Mr. David Malka
Employees
11
Headquarters
19 Ha'Yahalomim Street, Ashdod
Founded
2013